Category: Generics Drugs
North America Generics Drugs
-
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325412
... Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 325412 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, ... Read More
-
Active Pharmaceutical Ingredient (API) Market in US 2024-2028
... period. The report on the active pharmaceutical ingredient (API) market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
US Generic Drug Market Report by Segment (Unbranded, Branded), Therapy Area (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) 2024-2032
... US generic drug market size reached US$ 90.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 124.3 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The ... Read More
-
Pharmaceutical Contract Manufacturing (3rd Edition), 2021-2030 Distribution by [A] business segment (API and FDF), [B] type of API (branded and generic), [C] type of FDF (oral solids, parenteral and others), [D] type of packaging form (blisters, bottles, injectables and others), [E] scale of operation (clinical and commercial), [F] end-users (large pharmaceutical companies, mid-sized pharmaceutical companies and small pharmaceutical companies) and [G] key geographical regions (North America, Europe, Asia-Pacific, Latin America, and Middle-East and North Africa): Industry Trends and Global Forecasts
... (blisters, bottles, injectables and others), [E] scale of operation (clinical and commercial), [F] end-users (large pharmaceutical companies, mid-sized pharmaceutical companies and small pharmaceutical companies) and [G] key geographical regions (North America, Europe, Asia-Pacific, Latin America, ... Read More
-
Plunkett's Health Care Industry Almanac 2024: Health Care Industry Market Research, Statistics, Trends and Leading Companies
... help shape strategy for business development, product development and investments. Key Features: Business trends analysis In-depth industry overview Technology trends analysis Forecasts Spending, investment, and consumption discussions In-depth industry statistics and metrics Industry employment numbers ... Read More
-
United States (US) Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
... forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The pharmaceuticals market consists of ethical drugs only and ... Read More
-
U.S. Generic Injectables Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Application, And Segment Forecasts, 2023 - 2030
... Growth & Trends The U.S. generic injectables pharmaceutical contract manufacturing market size is expected to reach USD 5.39 billion by 2030, according to a new report by Grand View Research, Inc. The U.S. market is ... Read More
-
G8 Countries Generics Market Summary, Competitive Analysis and Forecast to 2027
... The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights G8 countries contributed $149,123.6 million in 2022 to the global generics industry, ... Read More
-
North America (NAFTA) Generics Market Summary, Competitive Analysis and Forecast to 2027
... 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The North American Free Trade Agreement (NAFTA) is a trade agreement ... Read More
-
Top 5 Emerging Countries Generics Market Summary, Competitive Analysis and Forecast to 2027
... forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights These countries contributed $139,492.2 million to the global generics ... Read More
-
United States (US) Generics Market Summary, Competitive Analysis and Forecast to 2027
... forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug ... Read More
-
Canada Generics Market Summary, Competitive Analysis and Forecast to 2027
... 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined ... Read More
-
Mexico Generics Market Summary, Competitive Analysis and Forecast to 2027
... 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined ... Read More
-
North America Generics Market Summary, Competitive Analysis and Forecast to 2027
... forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug ... Read More
-
United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 47.0 Billion by 2028, exhibiting a growth rate (CAGR) of 9.6% during 2023-2028. Specialty generic drugs are the generic versions of specialty branded drugs once they lose patent protection. These drugs ... Read More
-
North America Specialty Generics Market Size, Share & Industry Trends Analysis Report
... Forecast, 2023 - 2030 The North America Specialty Generics Market would witness market growth of 9.0% CAGR during the forecast period (2023-2030). The complex or high-end specialty generics are generic equivalents of drugs. However, they ... Read More
-
US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 32.7 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028. A generic injectable refers to a bioequivalent of the branded pharmaceutical needle with the same active ingredients and therapeutic effects. ... Read More
-
Global HIV Treatment Market: Analysis By Product (Atripla, Biktarvy, Descovy, Genovya, Odefsey, Truvada, Sunlenca (Lenacapavir), Dovato, Juluca, Tivicay, Triumeq, Cabenuva, VH184, Capsid, bNAbs, Islatravir, and Generics), By Region (The US, and EU + ROW) Size and Trends with Impact of COVID-19 and Forecast up to 2030
... and Trends with Impact of COVID-19 and Forecast up to 2030 The global HIV treatment market in 2022 stood at US$22.38 billion, and is likely to reach US$25.49 billion by 2030. HIV treatment, also known ... Read More
-
United States Pharmaceutical Logistics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... Highlights Transportation problems were making it hard to distribute COVID-19, which was causing problems in the drug supply chain.Port disruptions, quarantined personnel, and labor shortages caused by lockdowns were all factors. Furthermore, COVID-19 slowed the ... Read More
-
United States Generic Drugs Market, Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis
... grow at a CAGR of 6.39% from 2022 to 2028. The pharmaceutical industry is vital for global healthcare, but it is important to distinguish between factors driving cost increases and those generating savings. Specialty drugs, ... Read More
-
US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 110.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4% during 2023-2028. Generics are off-patented drugs that are bioequivalent to branded medications in terms of dosage, strength, quality, form, effect, intended use, side effects, ... Read More
-
North America Pulmonary Arterial Hypertension Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Drugs [Endothelin Receptor Antagonists (ERAs), Prostacyclin and Prostacyclin Analogs, sGC Stimulators, and pde-5 Dipsticks], Type (Branded and Generics), Route of Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies)
... Route of Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies) The North America pulmonary arterial hypertension market is expected to grow from US$ 3,147.76 million in ... Read More
-
North America Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The branded generics market in North ... Read More
-
North America Inhalation and Nasal Spray Generic Drugs Market Size, Share & Industry Trends Analysis Report By End-user, By Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis), By Distribution Channel, By Demographics, By
... and Growth Forecast, 2022 – 2028 The North America Inhalation and Nasal Spray Generic Drugs Market would witness market growth of 8.0% CAGR during the forecast period (2022-2028). Inhalation therapy involves dispersing medications into the ... Read More
-
Prebiotics for Dietary Supplements Market, by Ingredient Type (Galacto-oligosaccharides (GOS), Fructo-oligosaccharides (FOS), Xylooligosaccharides (XOS), Isomaltooligosaccharides (IMO) and Human milk oligosaccharides (HMO)), by Source (Plant (Including Botanicals) and Animal), by Distribution Channel (B2B (Generic) (Broker and Direct (supplier to client)), B2C (Branded) (Pharmacies, Specialty Stores, and Hypermarket and supermarket)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Direct (supplier to client)), B2C (Branded) (Pharmacies, Specialty Stores, and Hypermarket and supermarket)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
Research Assistance
